Search Results - "Tsolakos, Nikos"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2

    Unexpected Functional Divergence of Bat Influenza Virus NS1 Proteins by Turkington, Hannah L, Juozapaitis, Mindaugas, Tsolakos, Nikos, Corrales-Aguilar, Eugenia, Schwemmle, Martin, Hale, Benjamin G

    Published in Journal of virology (01-03-2018)
    “…Recently, two influenza A virus (FLUAV) genomes were identified in Central and South American bats. These sequences exhibit notable divergence from classical…”
    Get full text
    Journal Article
  3. 3

    Comparative toxicological assessment of cigarettes and new category products via an in vitro multiplex proteomics platform by Tsolakos, Nikos, Haswell, Linsey E., Miazzi, Fabio, Bishop, Emma, Antoranz, Asier, Pliaka, Vaia, Minia, Angeliki, Alexopoulos, Leonidas G., Gaca, Marianna, Breheny, Damien

    Published in Toxicology reports (01-06-2024)
    “…Cigarette smoking is a risk factor for several diseases such as cancer, cardiovascular disease (CVD), and chronic obstructive pulmonary diseases (COPD),…”
    Get full text
    Journal Article
  4. 4

    Protein kinase D drives the secretion of invasion mediators in triple-negative breast cancer cell lines by Gali, Alexia, Bijnsdorp, Irene V., Piersma, Sander R., Pham, Thang V., Gutiérrez-Galindo, Elena, Kühnel, Fiona, Tsolakos, Nikos, Jimenez, Connie R., Hausser, Angelika, Alexopoulos, Leonidas G.

    Published in iScience (16-02-2024)
    “…The protein kinase D (PKD) family members regulate the fission of cargo vesicles at the Golgi complex and play a pro-oncogenic role in triple-negative breast…”
    Get full text
    Journal Article
  5. 5

    Epicardial Adipose Tissue as an Independent Cardiometabolic Risk Factor for Coronary Artery Disease by Karampetsou, Nikoleta, Alexopoulos, Leonidas, Minia, Aggeliki, Pliaka, Vaia, Tsolakos, Nikos, Kontzoglou, Konstantinos, Perrea, Despoina N, Patapis, Paulos

    Published in Curēus (Palo Alto, CA) (01-06-2022)
    “…During the last decades, visceral adiposity has been at the forefront of scientific research because of its complex role in the pathogenesis of cardiovascular…”
    Get full text
    Journal Article
  6. 6

    A GMP-Compliant Procedure for the Generation of Gene-Modified T cells by Savvopoulos, Nikolaos, Stampolitis, Klearchos, Alexandropoulos, Georgios, Kefala, Dionysia, Lysandrou, Memnon, Zacharioudaki, Vassiliki, Tsolakos, Nikos, Spyridonidis, Alexandros

    Published in Journal of visualized experiments (06-10-2023)
    “…The field of Adoptive Cell Therapy (ACT) has been revolutionized by the development of genetically modified cells, specifically Chimeric Antigen Receptor…”
    Get more information
    Journal Article
  7. 7

    Comparison of the toxicological potential of two JUUL ENDS products to reference cigarette 3R4F and filtered air in a 90-day nose-only inhalation toxicity study by Desai, Rahat Wadhwa, Demir, Kubilay, Tsolakos, Nikos, Moir-Savitz, Tessa R., Gaworski, Charles L., Weil, Roxana, Oldham, Michael J., Lalonde, Guy

    Published in Food and chemical toxicology (01-09-2023)
    “…Electronic nicotine delivery systems (ENDS) are generally recognized as less harmful alternatives for those who would otherwise continue to smoke cigarettes…”
    Get full text
    Journal Article
  8. 8

    Subchronic inhalation of a novel electronic nicotine delivery system formulation and its corresponding base formulation by Lalonde, Guy, Tsolakos, Nikos, Moir-Savitz, Tessa R, Easley, Alex M, Gaworski, Charles L, Oldham, Michael J

    Published in Human & experimental toxicology (01-01-2024)
    “…Fresh Menthol 3% Nicotine (FM3) is a novel JUUL e-liquid formulation. Its potential toxicity and that of the corresponding base formulation relative to a…”
    Get full text
    Journal Article
  9. 9

    Identification of vaccine antigens using integrated proteomic analyses of surface immunogens from serogroup B Neisseria meningitidis by Tsolakos, Nikos, Brookes, Charlotte, Taylor, Stephen, Gorringe, Andrew, Tang, Christoph M., Feavers, Ian M., Wheeler, Jun X.

    Published in Journal of proteomics (14-04-2014)
    “…Meningococcal surface proteins capable of evoking a protective immune response are candidates for inclusion in protein-based vaccines against serogroup B…”
    Get full text
    Journal Article
  10. 10

    Characterization of meningococcal serogroup B outer membrane vesicle vaccines from strain 44/76 after growth in different media by Tsolakos, Nikos, Lie, Kristian, Bolstad, Karin, Maslen, Sarah, Kristiansen, Paul A, Høiby, E. Arne, Wallington, Amanda, Vipond, Caroline, Skehel, Mark, Tang, Christoph M, Feavers, Ian M, Wedege, Elisabeth, Wheeler, Jun X

    Published in Vaccine (19-04-2010)
    “…Abstract In this study, we evaluated the effect of the growth medium on the composition and immunogenicity of meningococcal outer membrane vesicle (OMV)…”
    Get full text
    Journal Article
  11. 11

    Comparison of two combinations of cyanine dyes for prelabelling and gel electrophoresis by Tsolakos, Nikos, Techanukul, Tanasit, Wallington, Amanda, Zhao, Yuan, Jones, Christopher, Nagy, Judit, Wheeler, Jun X.

    Published in Proteomics (Weinheim) (01-03-2009)
    “…We report the use of IC‐OSu ethyl‐Cy3 and ethyl‐Cy5 N‐hydroxysuccinimide ester (NHS) cyanine dyes, which have similar chemical properties as the CyDye™ DIGE…”
    Get full text
    Journal Article